Resources
Advanced Search
Start Free Trial
Talk With Sales
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
AkaRx
Growth Score
7
CB Rank
3913387
Heat Score
20
Save
Actions
AkaRx develops therapeutics including the orally-available small molecule for use in the treatment of thrombocytopenia.
Acquired by
Eisai
Founded
obfuscated
obfuscation
Private
Venture - Series Unknown
Paramus
,
New Jersey
,
United States
Biopharma
Biotechnology
Therapeutics
AkaRx
Section: Overview
Actions